Key Market Indicators
Norwegian insulin imports are projected to decline significantly, reaching approximately $3.6 million by 2028. This marks a sharp drop from the $6.3 million recorded in 2023, reflecting an average annual decrease of 9.1%. The trend is consistent with a long-term decline in demand, which has seen a year-on-year reduction of 3.9% since 1998. On the export front, Norway experienced a dramatic fall in insulin shipments. In 2018, exports totaled just $6,000, a staggering decrease from $4.1 million in 2017—a drop of 99.9% in just one year. This decline is part of a broader trend observed since 2006, during which Norwegian insulin supply has decreased by an average of 78.4% annually.
